Skip to content
DeepViews

Balchem Corporation (BCPC) — Analysis Summary

Balchem Corporation (BCPC) has a market cap of $5.69B with year-over-year revenue growth of +8.8%. Net margin stands at 14.9%. The stock trades at a P/E ratio of 34.6.

Key Takeaways

  • Revenue changed +8.8% year-over-year
  • Net margin of 14.9%
  • P/E ratio of 34.6

Compared to other companies in the CHEMICALS & ALLIED PRODUCTS sector, BCPC posted revenue growth of +8.8% and trades at a P/E of 34.6.

[XNAS]

Balchem Corporation (BCPC)

$178.44

UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$5688.31M
Enterprise Value
$5625.14M
P/E Ratio
34.6
Div Yield
0.54%
EV/EBITDA
20.9
Company Profile
About
About Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Sector

CHEMICALS & ALLIED PRODUCTS

Employees

1,379

Headquarters

MONTVALE, NJ

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
61
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$1302.38M
Total Debt$0.00M
Debt-to-Equity0.00
Cash & Equivalents$63.17M

Cash Flow

Operating Cash Flow$219.62M
Free Cash Flow$0.00M
FCF Margin0.00%
P/FCF RatioN/A
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$0.96

Dividend Yield

0.54%

Annual
Last Ex-Date: 2025-12-23

Dividend History

2025-12-23
CD$0.9600
2024-12-26
CD$0.8700
2023-12-26
CD$0.7900
2022-12-23
CD$0.7100
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.